Duchenne muscular dystrophy: overcomingcurrent challenges on CRISPR-based gene therapy through DNA-based nanomaterials
Principal researcher:
Laura Ordovás
Managing entity:
SGI - Universidad de Zaragoza
Scope:
Nacional
Entidades participantes:
Universidad de Zaragoza
CIC biomaGUNE
Number of researchers:
4
Start date:
01/2020
End date:
12/2021